Top Anatomic Pathology Companies

Anatomic Pathology Market size was valued at USD 40.46 Billion in 2024 and is poised to grow from USD 43.42 Billion in 2025 to USD 76.29 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026–2033).

Global anatomic pathology market is fairly consolidated with the presence of many well-known international and regional companies operating around the globe. Major players of the market are implementing on several business strategies including research & development, new product launches, collaborations, mergers, and partnerships to maintain their market share and expand their product portfolio to reach a wider consumer base. 'F. Hoffman-LA Roche Ltd. ', 'Danaher Corporation ', 'PHC Holdings Corporation ', 'Abcam Plc. ', 'Hologic, Inc. ', 'Agilent Technologies ', 'Becton, Dickinson And Company ', 'Sakura Finetek USA Inc. ', 'Merck KGAA ', 'Bio SB ', 'Quest Diagnostics Incorporated ', 'Laboratory Corporation of America Holdings ', 'Cardinal Health ', 'NeoGenomics Laboratories, Inc. ', 'BioGenex ', 'Thermo Fisher Scientific Inc. ', 'Bio-Rad Laboratories, Inc. ', 'Siemens AG ', 'Cell Signaling Technology, Inc. ', 'PerkinElmer Inc.'

The increasing prevalence of various types of chronic diseases, as well as changes in consumer lifestyle and food habits, are the key major factors expected to drive the global anatomic pathology market during the forecast period. According to our findings, the global population of people over the age of 65 was around 727 million in 2020 and is expected to reach 1.5 billion by 2050. Since then, the tremendous growth in the global population of the elderly is expected to create significant growth opportunities for the anatomic pathology market in the coming years.

Increasing usage of advanced pathology equipment like digital microscopes, staining systems, and gross imaging is creating lucrative growth opportunities for the global market over the coming years. The features such as providing accuracy, specificity over the conventional techniques, and ease to use are enhancing the adoption of advanced anatomic pathology devices around the globe, thereby, the market is witnessing a strong growth in the coming years.

Globally, North America dominated the anatomic pathology market and accounted for the largest market share in 2021 and its set to continue this dominance throughout the forecast period. Increasing implementation of digital pathology, early adoption of advanced imaging tools, and rising consumer awareness regarding regular health screening are the few major factors likely to drive the growth of the market in the region over the coming years. In addition, presence of many well-known market players such as Pfizer Inc., Johnson & Johnson Pvt Ltd., and Abbott Laboratories in the region is also propelling the growth of the anatomic pathology market.